VB
Valion Bio, Inc.
VBIO · NASDAQ
$2.49 +2.68% (+$0.07)
1M -40.00%
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
PEG N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
-
N/A ROIC N/A
Asset turnover N/A
ROE N/A
Debt
-
N/A Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio N/A
Stability
9 /100
Unstable Beta 1.79x
Rev. volatility N/A
Profitable years N/A
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre VBIO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Michael R. Cavanaugh
Employees
52
Headquarters
San Antonio
Evenimente viitoare
13 NOV.
Earnings
Upcoming earnings report